Discover

RZLT
Rezolute, Inc.
3.84
1 x 3.90
1 x 4.02
bid
ask
-
0.11
2.78%
1 @ 07:30 PM
3.83 -0.01 (0.26%)
Ytd62.71%
1y-53.17%
3.67
day range
3.95
1.40
52 week range
10.94
Open3.95Prev Close3.95Low3.67High3.95Mkt Cap369.76M
Vol2.53MAvg Vol1.58MEPS-0.81P/EN/AForward P/E-3.42
Beta1.19Short Ratio3.16Inst. Own64.24%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning09-2150-d Avg4.68200-d Avg3.901yr Est13.00

RZLT News

Rezolute, Inc. (NASDAQ:RZLT) Receives $9.38 Average Price Target from Analysts
defenseworld.net
Rezolute, Inc. (NASDAQ:RZLT) Receives $9.38 Average Price Target from Analysts

Shares of Rezolute, Inc. (NASDAQ: RZLT - Get Free Report) have earned a consensus recommendation of

benzinga.com
Rezolute Said FDA Is Still Reviewing Ersodetug Submission In Congenital Hyperinsulinism; The Company

Data from the Phase 3 sunRIZE study remains under review by FDA The OLE Phase of the study is ongoin

Rezolute Provides Update on FDA Review of its Phase 3 sunRIZE Study Results in Congenital Hyperinsulinism
globenewswire.com
Rezolute Provides Update on FDA Review of its Phase 3 sunRIZE Study Results in Congenital Hyperinsul

Data from the Phase 3 sunRIZE study remains under review by FDA  The OLE Phase of the study is ongoi

Rezolute to Participate in Upcoming Investor Conferences
globenewswire.com
Rezolute to Participate in Upcoming Investor Conferences

REDWOOD CITY, Calif., Sept. 02, 2026 (GLOBE NEWSWIRE) -- Rezolute, Inc. (Nasdaq: RZLT) (“Rezolute” o

Rezolute, Inc. $RZLT Shares Sold by Bank of America Corp DE
defenseworld.net
Rezolute, Inc. $RZLT Shares Sold by Bank of America Corp DE

Bank of America Corp DE reduced its stake in Rezolute, Inc. (NASDAQ: RZLT) by 31.3% during the undef

MARA Holdings, Coinbase Global, Ternium And Other Big Stocks Moving Higher On Friday
benzinga.com
MARA Holdings, Coinbase Global, Ternium And Other Big Stocks Moving Higher On Friday

Dow Jones index gained around 350 points on Friday. MARA Holdings Inc (NASDAQ: MARA) rose sharply, w

Rezolute to Participate in the BTIG Virtual Biotechnology Conference
globenewswire.com
Rezolute to Participate in the BTIG Virtual Biotechnology Conference

REDWOOD CITY, Calif., July 21, 2026 (GLOBE NEWSWIRE) -- Rezolute, Inc. (Nasdaq: RZLT) (“Rezolute” or

benzinga.com
Rezolute Highlights ENDO Data On Congenital HI Outcomes And Tumor HI Case Series Supporting Ersodetu

Presentations included analyses of natural history and adverse outcomes in congenital hyperinsulinis

Rezolute Highlights Results Presented from Natural History Outcomes Studies and its Ersodetug Clinical Program in Hyperinsulinism at Annual Meeting of the Endocrine Society
globenewswire.com
Rezolute Highlights Results Presented from Natural History Outcomes Studies and its Ersodetug Clinic

Presentations included analyses of natural history and adverse outcomes in congenital hyperinsulinis

benzinga.com
Guggenheim Maintains Buy on Rezolute, Raises Price Target to $11

Guggenheim analyst Debjit Chattopadhyay maintains Rezolute (NASDAQ:RZLT) with a Buy and raises th

RZLT Stock on the Move: What Sparks the 38% Jump in the Past Week?
zacks.com
RZLT Stock on the Move: What Sparks the 38% Jump in the Past Week?

Rezolute rises 38% in a week after interim upLIFT data shows most tumor HI patients cut or eliminate

benzinga.com
Rezolute To Present Four Presentations At Upcoming Annual Meeting Of Endocrine Society

Rezolute, Inc. (NASDAQ:RZLT) ("Rezolute" or the "Company"), a late-stage ultra-rare

Rezolute Announces Four Presentations at the Upcoming Annual Meeting of the Endocrine Society
globenewswire.com
Rezolute Announces Four Presentations at the Upcoming Annual Meeting of the Endocrine Society

REDWOOD CITY, Calif., June 04, 2026 (GLOBE NEWSWIRE) -- Rezolute, Inc. (Nasdaq: RZLT) (“Rezolute” or

benzinga.com
Maxim Group Maintains Buy on Rezolute, Raises Price Target to $14

Maxim Group analyst Jason McCarthy maintains Rezolute (NASDAQ:RZLT) with a Buy and raises the pri

Navitas Semiconductor, Abivax, MiniMed And Other Big Stocks Moving Higher On Wednesday
benzinga.com
Navitas Semiconductor, Abivax, MiniMed And Other Big Stocks Moving Higher On Wednesday

Dow falls 296 points. Navitas Semi rises on partnership with Nvidia. Other gainers: ABVX, MMED, KELY

benzinga.com
Citizens Upgrades Rezolute to Market Outperform, Announces $11 Price Target

Citizens analyst Jason N. Butler upgrades Rezolute (NASDAQ:RZLT) from Market Perform to Market Ou

benzinga.com
Wedbush Maintains Outperform on Rezolute, Raises Price Target to $6

Wedbush analyst Yun Zhong maintains Rezolute (NASDAQ:RZLT) with a Outperform and raises the price

Marvell Technology Soars on NVIDIA CEO's Endorsement, Joins Relmada Therapeutics and Other Big Stocks Moving Higher in Wednesday's Pre-Market Session
benzinga.com
Marvell Technology Soars on NVIDIA CEO's Endorsement, Joins Relmada Therapeutics and Other Big Stock

U.S. stock futures surged on Wed. as Nasdaq futures rose over 7%, driven by AI. Marvell's stock

Rezolute Highlights Strong Early Response Trends In Rare Hypoglycemia Disease Study
benzinga.com
Rezolute Highlights Strong Early Response Trends In Rare Hypoglycemia Disease Study

Rezolute, Inc. (NASDAQ:RZLT) reported an interim update from its ongoing Phase 3 upLIFT study evalua

Rezolute Highlights Strong Early Response Trends In Rare Hypoglycemia Disease Study
benzinga.com
Rezolute Highlights Strong Early Response Trends In Rare Hypoglycemia Disease Study

Rezolute says 6 of 8 patients met the primary endpoint in its Phase 3 upLIFT study of ersodetug for

benzinga.com
HC Wainwright & Co. Reiterates Buy on Rezolute, Maintains $5 Price Target

HC Wainwright & Co. analyst Douglas Tsao reiterates Rezolute (NASDAQ:RZLT) with a Buy and mai

benzinga.com
Rezolute Reports Mid-Study Results for Rare Hypoglycemia Treatment

Rezolute, Inc. (NASDAQ:RZLT) ("Rezolute" or the "Company"), a late-stage ultra-rare

Rezolute Announces Positive Interim Data for its Phase 3 upLIFT Study of Ersodetug in Tumor Hyperinsulinism
globenewswire.com
Rezolute Announces Positive Interim Data for its Phase 3 upLIFT Study of Ersodetug in Tumor Hyperins

Study now 50% enrolled 6 of 8 participants have already met the responder criterion for the study's

Rezolute Reports Third Quarter Fiscal 2026 Financial Results and Provides Business Update
globenewswire.com
Rezolute Reports Third Quarter Fiscal 2026 Financial Results and Provides Business Update

REDWOOD CITY, Calif., May 12, 2026 (GLOBE NEWSWIRE) -- Rezolute, Inc. (Nasdaq: RZLT) (“Rezolute” or

Rezolute to Participate in Upcoming Investor Conferences
globenewswire.com
Rezolute to Participate in Upcoming Investor Conferences

REDWOOD CITY, Calif., May 11, 2026 (GLOBE NEWSWIRE) -- Rezolute, Inc. (Nasdaq: RZLT) (“Rezolute” or

Rezolute Announces Oral Presentation of Results From its Phase 3 sunRIZE Study of Ersodetug in Patients with Congenital Hyperinsulinism at the Pediatric Endocrine Society Annual Meeting
globenewswire.com
Rezolute Announces Oral Presentation of Results From its Phase 3 sunRIZE Study of Ersodetug in Patie

Includes results from additional continuous glucose monitoring (CGM)-based outcomes which demonstrat

Rezolute, Inc. Investigated by the Portnoy Law Firm
globenewswire.com
Rezolute, Inc. Investigated by the Portnoy Law Firm

LOS ANGELES, April 24, 2026 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Rezolute, Inc., (“Rezol

Rezolute to Present Results from its Phase 3 sunRIZE Study in Congenital Hyperinsulinism at the Pediatric Endocrine Society (PES) Annual Meeting
globenewswire.com
Rezolute to Present Results from its Phase 3 sunRIZE Study in Congenital Hyperinsulinism at the Pedi

Oral presentation will include previously announced topline results as well as pre-specified and pos

Rezolute Stock Gains After FDA Meeting on Ersodetug Program Update
zacks.com
Rezolute Stock Gains After FDA Meeting on Ersodetug Program Update

RZLT stock jumps 12% after an FDA meeting highlights ersodetug data and next steps, despite an earli

FDA Review Puts Rezolute's Genetic Disorder Drug Path In Question
benzinga.com
FDA Review Puts Rezolute's Genetic Disorder Drug Path In Question

In a recent update, Rezolute shared insights from its March 17 meeting with the FDA regarding its Ph

Rezolute Provides Update on its Congenital Hyperinsulinism Program Following FDA Meeting
globenewswire.com
Rezolute Provides Update on its Congenital Hyperinsulinism Program Following FDA Meeting

REDWOOD CITY, Calif., March 24, 2026 (GLOBE NEWSWIRE) -- Rezolute, Inc. (Nasdaq: RZLT) (“Rezolute” o

Reviewing Rezolute (NASDAQ:RZLT) & ADMA Biologics (NASDAQ:ADMA)
defenseworld.net
Reviewing Rezolute (NASDAQ:RZLT) & ADMA Biologics (NASDAQ:ADMA)

ADMA Biologics (NASDAQ: ADMA - Get Free Report) and Rezolute (NASDAQ: RZLT - Get Free Report) are bo

RZLT INVESTOR ALERT: Faruqi & Faruqi, LLP Launches Investigation into Rezolute
businesswire.com
RZLT INVESTOR ALERT: Faruqi & Faruqi, LLP Launches Investigation into Rezolute

NEW YORK--(BUSINESS WIRE)---- $RZLT #ClassAction--Faruqi & Faruqi, LLP, a leading national securitie

12 Health Care Stocks Moving In Tuesday's Intraday Session
benzinga.com
12 Health Care Stocks Moving In Tuesday's Intraday Session

12 Health Care Stocks Moving In Monday's Intraday Session
benzinga.com
12 Health Care Stocks Moving In Monday's Intraday Session

12 Health Care Stocks Moving In Friday's After-Market Session
benzinga.com
12 Health Care Stocks Moving In Friday's After-Market Session

12 Health Care Stocks Moving In Thursday's Intraday Session
benzinga.com
12 Health Care Stocks Moving In Thursday's Intraday Session

Oxford Industries, Ur-Energy, Oracle And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
benzinga.com
Oxford Industries, Ur-Energy, Oracle And Other Big Stocks Moving Lower In Thursday's Pre-Market Sess

benzinga.com
12 Health Care Stocks Moving In Monday's Intraday Session

benzinga.com
Adobe, Avidity Biosciences And 3 Stocks To Watch Heading Into Friday

benzinga.com
12 Health Care Stocks Moving In Wednesday's Pre-Market Session

benzinga.com
Stocks That Hit 52-Week Lows On Wednesday

  On Wednesday, 311 stocks hit new 52-week lows.

benzinga.com
Stocks That Hit 52-Week Lows On Monday

  On Monday, 369 companies set new 52-week lows.

benzinga.com
Stocks That Hit 52-Week Lows On Friday

  During Friday, 125 stocks hit new 52-week lows.

benzinga.com
Stocks That Hit 52-Week Lows On Thursday

  On Thursday, 111 stocks hit new 52-week lows.

benzinga.com
Stocks That Hit 52-Week Lows On Tuesday

  On Tuesday, 120 companies set new 52-week lows.

benzinga.com
58 Biggest Movers From Friday

Gainers BEST Inc. (NYSE: BEST) shares gained 73.6% to close at $1.00. DiDi Global Inc. (NYSE: D

benzinga.com
45 Stocks Moving In Friday's Mid-Day Session

Gainers Grom Social Enterprises, Inc. (NASDAQ: GROM) jumped 62.4% to $1.5500. DiDi Global Inc.

benzinga.com
39 Stocks Moving In Wednesday's Mid-Day Session

Gainers Jasper Therapeutics, Inc. (NASDAQ: JSPR) shares jumped 113% to $15.36 after Oppenheimer

benzinga.com
36 Stocks Moving In Tuesday's Mid-Day Session

Gainers Orbital Energy Group, Inc. (NASDAQ: OEG) shares jumped 67.3% to $5.94 after the company a